As Economist Impact’s World Cancer Series continues, Day Two firmly takes up focus on the patient voice, with a presentation by Eileen Page, chief executive of Innovation Advantage 2020 to
Today is set to kick off with a welcome chair of healthcare at Economist Impact, Vivek Muthu, followed by a keynote speech on ‘Cancer control: Global perspectives and European solutions’ by
Modern medicine moves ever more to precision, personalised medicine, and precision dosing is critical in a world that recognises biological individuality – especially when it comes to paedi